Jubilant Pharmova Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova Limited has submitted a routine compliance certificate to the stock exchanges for the quarter ended December 31, 2025. The certificate was issued by Alankit Assignments Limited, the company's Registrar and Share Transfer Agent, confirming that all physical share certificates received for dematerialization have been verified, mutilated, cancelled, and replaced by the respective depository as the registered owner. The filing was signed by Naresh Kapoor, Company Secretary, on January 6, 2026. This is a standard procedural submission required by SEBI regulations and contains no new business or financial information.
No impact on shareholders or stock price. This is a routine regulatory filing confirming proper handling of share dematerialization requests, with no change in the company's fundamentals or capital structure.